User:SDZeroBot/NPP sorting/STEM/Chemistry
| Tutorial | Discussion | New page feed | Reviewers | Curation tool Suggestions | Coordination |
 | 12 unreviewed articles as of 9 August 2025
|
| Created | Article | Extract | Class | Creator (# edits) | Notes |
|---|---|---|---|---|---|
| 2024-11-10 | Qing-Yun Chen (Chinese chemist (1929-2023)) | Qing-Yun Chen (Chinese: 陈庆云; pinyin: Chén Qìngyún; 25 January 1929 – 2 March 2023) was a Chinese organic chemist and member of the Chinese Academy of Sciences, specializing in the field of organic fluorine chemistry. | Start | Tokisaki Kurumi (8288) | |
| 2024-12-17 | Dazadrol (Dazadrol is an antidepressant) | Dazadrol is a synthetic antidepressant developed by Schering Corp in the late 1960s. It acts primarily as a noradrenaline reuptake inhibitor, increasing concentrations of noradrenaline in the synaptic cleft, which is believed to underlie its antidepressant effects. | Stub | Mo18ekula (260) | |
| 2025-05-19 | Transition metal catalytic asymmetric dearomatization reactions (Category of organic chemical reactions) | Catalyzed asymmetric dearomatization reactions (CADA reactions) are a category of asymmetric dearomatization reactions that catalytically transform aromatic compounds into enantioenriched polycycles and heterocyclic skeletons. The term was coined in 2012 by You et al. | FA | PchemExtraordinaire (38) | |
| 2025-05-23 | Cefepime/sulbactam (Combination antibiotic consisting of the IV generation) | Cefepime/sulbactam is a 1:1 fixed-dose combination of cefepime (a fourth-generation cephalosporin) and sulbactam (a β-lactamase inhibitor). The combination exerts a bactericidal effect by disrupting bacterial cell wall synthesis through transpeptidase inhibition, thereby impairing peptidoglycan cross-linking. | C | Хокус Покус 333 (37) | |
| 2025-05-31 | Musahaqah | Musaheqeh (Arabic: مساحقه) is a legal and religious term. In Islamic jurisprudence (fiqh) and under the Islamic Penal Code of Iran, musaheqeh refers to a situation in which an adult, mentally competent, and consenting woman brings her genitalia into contact with the genitalia of another woman. | Stub | JesusisGreat7 (2459) | |
| 2025-07-16 | IHCH-8134 (Chemical compound) | IHCH-8134 is a drug of the oxazinopyridoindole family which acts as an agonist at the 5-HT2A serotonin receptor. It was derived by structural simplification of the 5-HT2A antagonist atypical antipsychotic drug lumateperone along with several related compounds such as IHCH-7079, which was found to be a non-hallucinogenic biased 5-HT2A agonist that was active in antidepressant assays but did not produce psychedelic-like responding in mice. | Stub | BaeyerDrewson (646) | |
| 2025-05-22 | 225Ac-PSMA-R2 (Investigational radiopharmaceutical) | 225Ac-PSMA-R2 is an investigational radiopharmaceutical developed by Novartis for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC). It is a targeted alpha therapy (TAT) combining actinium-225 (225Ac), an alpha-emitting radionuclide, with PSMA-R2, a small-molecule ligand targeting prostate-specific membrane antigen (PSMA), a protein overexpressed in prostate cancer cells. | C | Noxoug1 (5566) | |
| 2025-07-17 | 177 Lu-NNS309 (Investigational radiopharmaceutical compound) | 177Lu-NNS309 is an investigational radiopharmaceutical compound currently under development by Novartis Pharmaceuticals for the treatment of various solid tumors. The compound is being evaluated in Phase I clinical trials for patients with pancreatic, lung, breast, and colorectal cancers. | C | Noxoug1 (5566) | |
| 2022-01-06 | Nitazenes (Class of drugs) | Nitazenes are a chemically defined class of substances derived from the parent compound nitazene. Nitazenes were developed in the second half of the 1950s by the Swiss Ciba AG as pain-relieving agents. They are important as centrally active, selective μ-opioid receptor agonists. | C | Idoghor Melody (38113) | |
| 2025-07-29 | OpRegen (Allogeneic cell therapy) | OpRegen (also known as RG6501) is an investigational allogeneic cell therapy developed by Lineage Cell Therapeutics for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The therapy consists of human retinal pigment epithelial (RPE) cells administered via subretinal injection as a single treatment. | C | Noxoug1 (5566) | |
| 2025-08-04 | Cinnabarinic acid (Chemical compound) | Cinnabarinic acid is a metabolite formed through the oxidative processing of tryptophan. It is an endogenous metabolite of the kynurenine pathway of tryptophan catabolism, formed by oxidative dimerization of two molecules of 3-hydroxyanthranilic acid. It functions both as a partial agonist at type 4 metabotropic glutamate receptors (mGlu₄) and as a ligand for the aryl hydrocarbon receptor (AhR), with implications for neuroprotection and immunomodulation. | Start | FlarpenX (37) | |
| 2025-08-08 | Sozinibercept (Pharmaceutical compound) | Sozinibercept was an investigational drug intended to be used to treat certain eye conditions such as wet age-related macular degeneration (AMD). It is administered intravitreally in combination with other Anti-VEGF-A including aflibercept, faricimab, ranibizumab, and bevacizumab. | Start | Mahmoudalrawi (2568) |
Last updated by SDZeroBot operator / talk at 13:52, 9 August 2025 (UTC)